Literature DB >> 10894576

Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study.

N J Talley1, G Holtmann, L Agréus, M Jones.   

Abstract

OBJECTIVE: It is unknown whether distinct functional GI (GI) symptom groupings occur in the general population and whether these are similar across different cultures. Although symptom-based diagnostic criteria have been developed for upper and lower GI syndromes (the Rome criteria), the classification is controversial. We aimed to identify whether independent symptom-based subgroups exist in four countries consistent with the Rome criteria.
METHODS: Random samples of the community were mailed a validated questionnaire based on the Bowel Disease Questionnaire in Rochester, MN (n = 2,220), in Sydney, Australia (n = 1,135), and in Essen, Germany (n = 500). A different validated questionnaire was mailed to a random sample in Osthammar, Sweden (n = 1,517). Only the common questions (n = 22) were used in the current analysis, and these were essentially identical in wording. The underlying structure of the item responses was examined using factor analysis. Initial factors were extracted using principal components analysis and then rotated using Varimax. Clustering of symptoms among individuals was examined though cluster analysis, using the factors as the basis for clustering.
RESULTS: Response rates varied from 64% to 80%; responders and nonresponders were similar sociodemographically. All four studies yielded similar factor structures. All countries reported symptom groupings consistent with the irritable bowel syndrome (IBS), dyspepsia and/or gastroesophageal reflux, and constipation; all except Sweden also had a diarrhea group. The cluster analysis yielded slightly more disparate results but a healthy group was present in all populations. All four populations had an IBS and/or bowel dysfunction cluster identified; a gastroesophageal reflux cluster was also present in all countries.
CONCLUSIONS: The similarity of factor and cluster structures found in these four nations suggest that patterns of GI symptoms and groupings of individuals are similar across these Western cultures. These results are consistent with the current international Rome classification for separate upper and lower functional GI disorders.

Entities:  

Mesh:

Year:  2000        PMID: 10894576     DOI: 10.1111/j.1572-0241.2000.02075.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

1.  Cluster's last stand.

Authors:  S C Howell; G D Eslick; N J Talley
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

2.  Acupuncture treatment in irritable bowel syndrome.

Authors:  A Schneider; P Enck; K Streitberger; C Weiland; S Bagheri; S Witte; H-C Friederich; W Herzog; S Zipfel
Journal:  Gut       Date:  2005-09-08       Impact factor: 23.059

3.  Does delayed gastric emptying really cause symptoms in functional dyspepsia? We still doubt it!

Authors:  N J Talley; G R Locke; J Tack
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

Review 4.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

5.  Prevalence and risk factors for abdominal bloating and visible distention: a population-based study.

Authors:  X Jiang; G R Locke; R S Choung; A R Zinsmeister; C D Schleck; N J Talley
Journal:  Gut       Date:  2008-06       Impact factor: 23.059

6.  Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.

Authors:  Brjánn Ljótsson; Michael Jones; Nicholas J Talley; Lars Kjellström; Lars Agréus; Anna Andreasson
Journal:  United European Gastroenterol J       Date:  2020-01-14       Impact factor: 4.623

7.  Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan.

Authors:  Shuichi Ohara; Tatsuyuki Kawano; Motoyasu Kusano; Teruo Kouzu
Journal:  J Gastroenterol       Date:  2011-02-26       Impact factor: 7.527

8.  Assessment of functional gastrointestinal disorders using the Gastro-Questionnaire.

Authors:  Rolf Leibbrand; Ulrich Cuntz; Wolfgang Hiller
Journal:  Int J Behav Med       Date:  2002

9.  The effect of tegaserod on symptoms and quality of life in korean women with irritable bowel syndrome with constipation.

Authors:  Yong Sung Kim; Suck Chei Choi; Jae Myung Park; Chang Hwan Choi; Dong Ho Lee; Hee Jung Son; In Kyung Sung; Jeong Jo Jeong; Joon Seong Lee; Ki Nam Shim; Kwang Jae Lee; Su Jin Hong; Myung-Gyu Choi
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

Review 10.  Applying case definition criteria to irritable bowel syndrome.

Authors:  Steven H Yale; A Kenneth Musana; Amy Kieke; Jennifer Hayes; Ingrid Glurich; Po-Huang Chyou
Journal:  Clin Med Res       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.